Atacicept in Combination With Rituximab in Subjects With Rheumatoid Arthritis (August III)
Clinical trial NCT00664521 · COMPLETED
Trial details
- NCT number
- NCT00664521
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2010-10-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.